Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
A Phase IIa Exploratory, Open label, Single Dose Regimen, Multiple Dose Testing Clinical
Study to Assess the Preliminary Efficacy, Tolerability and Pharmacokinetics of OZ439 in adult
patients with acute, uncomplicated Plasmodium falciparum or vivax malaria mono-infection.